Masked Comparison of a New PEG Based Artificial Tear and Optive for Comfort, Vision & Wear Time in Patients Wearing Contact Lenses
Phase 4
Completed
- Conditions
- Comfort, Vision and Wear Time
- Interventions
- Drug: New PEG based artificial tearDrug: Optive
- First Posted Date
- 2007-12-11
- Last Posted Date
- 2010-02-22
- Lead Sponsor
- Bp Consulting, Inc
- Target Recruit Count
- 50
- Registration Number
- NCT00570843
- Locations
- 🇺🇸
The New York Presbyterian Hospital-Weill Cornell Medical College, New York, New York, United States
© Copyright 2025. All Rights Reserved by MedPath